Description

1-(8-Methyl-2-Phenyl-Imidazo[1,2-A]Pyridin-3-Ylmethyl)-Piperidine-4-Carboxylic Acid is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is of significant value for research and development in medicinal chemistry, particularly for its potential role as a key building block in novel active pharmaceutical ingredients (APIs). It is primarily sought by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the synthesis of new therapeutic agents, especially within the domains of central nervous system (CNS) and anti-inflammatory drug discovery.

Application

• Pharmaceutical Intermediate: A critical precursor in the multi-step synthesis of novel drug candidates, particularly those targeting neurological pathways.
• Medicinal Chemistry Research: Serves as a versatile scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• API Synthesis: Used in the development and potential commercial production of new Active Pharmaceutical Ingredients (APIs) with imidazopyridine cores.
• Biochemical Tool Compound: May be utilized in biochemical assays and as a reference standard for pharmacological studies.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for the pharmaceutical industry.

Basic Information

Product Name	1-(8-Methyl-2-Phenyl-Imidazo[1,2-A]Pyridin-3-Ylmethyl)-Piperidine-4-Carboxylic Acid
CAS No.	727977-57-3
Molecular Formula	C21H23N3O2
Molecular Weight	349.43 g/mol
Synonyms	1-[(8-Methyl-2-phenylimidazo[1,2-a]pyridin-3-yl)methyl]piperidine-4-carboxylic acid; 1-(8-Methyl-2-phenylimidazo[1,2-a]pyridin-3-ylmethyl)piperidine-4-carboxylic acid; 727977-57-3; UNII-9J8F9K2F6I; 9J8F9K2F6I; 1-((8-Methyl-2-phenylimidazo[1,2-a]pyridin-3-yl)methyl)piperidine-4-carboxylic acid; Piperidine-4-carboxylic acid, 1-[(8-methyl-2-phenylimidazo[1,2-a]pyridin-3-yl)methyl]-
EINECS	Contact for details

Quality Control

Our production of 1-(8-Methyl-2-Phenyl-Imidazo[1,2-A]Pyridin-3-Ylmethyl)-Piperidine-4-Carboxylic Acid adheres to stringent quality management protocols. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the exacting standards required for pharmaceutical R&D. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting purity, related substances, and other critical parameters.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). The compound may be hygroscopic (moisture-sensitive); therefore, the container should be kept tightly sealed under inert atmosphere if specified.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Any single impurity ≤ 0.5%, Total impurities ≤ 2.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.